Eli Lilly and Co (LLY)
732.20
-13.49
(-1.81%)
USD |
NYSE |
Apr 24, 16:00
725.21
-6.99
(-0.95%)
Pre-Market: 05:19
Eli Lilly Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 750.00M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 1.50B |
December 31, 2021 | 750.00M |
September 30, 2021 | 0.00 |
June 30, 2021 | 500.00M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 500.00M |
December 31, 2019 | 300.00M |
September 30, 2019 | 600.00M |
June 30, 2019 | 0.00 |
March 31, 2019 | 3.50B |
December 31, 2018 | 1.10B |
September 30, 2018 | -659.70M |
June 30, 2018 | 950.70M |
March 31, 2018 | 1.10B |
December 31, 2017 | 99.90M |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 199.90M |
March 31, 2017 | |
December 31, 2016 | 300.00M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 300.10M |
December 31, 2015 | 252.90M |
September 30, 2015 | 61.10M |
June 30, 2015 | 124.90M |
March 31, 2015 | 310.60M |
December 31, 2014 | 300.00M |
September 30, 2014 | 300.00M |
June 30, 2014 | 145.00M |
March 31, 2014 | 55.00M |
December 31, 2013 | 500.00M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 1.198B |
December 31, 2012 | 721.10M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | |
September 30, 2011 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
1.50B
Maximum
Mar 2022
257.89M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
Amgen Inc | 0.00 |
Biogen Inc | 0.00 |
Madrigal Pharmaceuticals Inc | -235.70M |
Vertex Pharmaceuticals Inc | 152.70M |
Viking Therapeutics Inc | 269.76M |